Bibliografia
Weinstein MC, Stason WB. Foundation of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977; 296: 716–21
Keeler EB, Cretin S. Discounting of live-saving and other nonmonetary effects. Management Science 1983; 29(3): 153–62
Drummond MF, O’Brien BJ, Stoddart GL, Torrance GW. Metodi per la valutazione economica dei programmi sanitari. II ed. Roma: Il Pensiero Scientifico Editore, 2000
Commonwealth Department of Human Services and Health. Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee. Canberra: Australian Government Publishing Service, 1995
Canadian Coordinating Office of Health Technology Assessment (CCOHTA). Guidelines for economic evaluation of pharmaceuticals: Canada. 2nd ed. Ottawa: CCOHTA, 1997
National Institute for Clinical Excellence. Guide to the Methods of Technology Appraisal. London: NICE, 2004
Garattini L, Grilli R, Scopelliti D, Mantovani L. A proposal for Italian guidelines in pharmacoeconomics. The Mario Negri Institute Centre for Health Economics. Pharmacoeconomics 1995; 7(1): 1–6
Attanasio E, Bruzzi P, Capri S, et al. Raccomandazioni per la conduzione degli studi di farmacoeconomia: la guida GISF. Mecosan 1999; 29: 65–72
Department of Health. Policy Appraisal and Health. London: Department of Health, 1996
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fattore, G. Costi ed efficacia devono essere scontati allo stesso tasso?. Pharmacoeconomics-Ital-Res-Articles 7, 5–7 (2005). https://doi.org/10.1007/BF03320531
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03320531